WebCidara Therapeutics is a biotech developing long-acting therapeutics designed to save lives and improve the standard of care for patients facing serious fungal or viral infections. Their current market cap is $125M and stock price is ~$3 at time of writing. Cidara Therapeutics has 2 primary therapeutics in phase 3 studies, Rezafungin and ... WebMar 1, 2024 · CDTX Stock Message Board for Investors. Cidara Therapeutics Inc. Stock Price, News and Company Updates. Message Board Total Posts: 5
CDTX Message Board - valueforum.com
WebCidara Therapeutics Inc is a biotechnology company. It is focused on the discovery, development, and commercialization of novel anti-infectives for the treatment and … WebFeb 27, 2024 · Cidara Therapeutics is a biotechnology company developing rezafungin, a long-acting echinocandin antifungal drug, for the treatment of invasive candidiasis and candidemia. Rezafungin showed non ... center for children \u0026 youth justice
CDTX - Cidara Therapeutics Inc Stock Price Quote - Morningstar
WebThe 911 Memorial Stair Climb. Lumberton Fire and EMS HCESD2228 Country Ln DrLumberton TX, 77657 (409) [email protected]@hcesd2.comGet … WebMar 20, 2024 · CDTX -4.04%. 88. See CDTX Report. Cidara Therapeutics Inc ( CDTX) has gained Monday morning, with the stock climbing 7.39% in pre-market trading to 1.89. CDTX's short-term technical score of 97 indicates that the stock has traded more bullishly over the last month than 97% of stocks on the market. In the Biotechnology industry, … WebApr 11, 2024 · In 2024, CDTX's revenue was $64.29 million, an increase of 29.69% compared to the previous year's $49.57 million. Losses were -$29.80 million, -29.83% less than in 2024. Financial Statements. buying a business dorset